Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,776 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06840756RecruitingPhase 4
Does donor-patient sex matching improve blood transfusion outcomes?
This trial tests whether giving ICU patients blood from a donor of the same sex (male-to-male or female-to-female) leads to better recovery compared to mismatched transfusions. The goal is to see if matching donor and patient sex makes a difference in how well patients do.
Hamilton, OntarioAges 18 years+ - NCT07200726Recruiting
Brain inflammation and thinking after heart surgery
This study looks at whether brain inflammation during heart surgery may affect memory and thinking. It includes people aged 60 and older who are having planned heart surgery.
Genk, LimburgAges 60 years+ - NCT07200817Recruiting
Blood markers to predict outcome in sepsis patients
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
CairoAges 18–70 - NCT07188350Recruiting
Electrical muscle stimulation for patients on a breathing machine
This trial tests whether low-level electrical pulses to the leg muscles can help prevent weakness in patients who need a breathing tube (ventilator) for more than 48 hours. It aims to see if this treatment helps patients recover faster.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT07548853RecruitingPhase 3
Testing TS-172 to Lower Phosphorus in Peritoneal Dialysis Patients
This study tests whether a new medicine called TS-172 can help lower phosphorus levels in patients on peritoneal dialysis (a type of kidney treatment). High phosphorus can cause bone problems and other complications, so the trial aims to see if this drug works better than current treatments.
TokyoAges 18 years+ - NCT06045247RecruitingPhase 2
Epcoritamab with low-intensity chemo for older or frail patients with new lymphoma
This study tests a new immunotherapy drug (epcoritamab) combined with a milder chemotherapy (rituximab-mini CVP) for older or frail patients who cannot receive standard strong chemo. It aims to effectively treat newly diagnosed diffuse large B-cell lymphoma with fewer side effects.
Houston, TexasAges 18 years+ - NCT07183111Recruiting
AI vs. regular instructions for braces patients
This trial compares standard instructions to AI-powered guidance (using a custom ChatGPT) to help patients with braces learn how to care for their teeth. It aims to see which method helps patients follow oral hygiene instructions better.
Islamabad, FederalAges 18–30 - NCT06547463Recruiting
Nasal airflow and sleep in tracheostomy patients
This study looks at how breathing through your nose affects sleep quality for patients with a tracheostomy who are on a ventilator at night. It involves a sleep test to measure your sleep patterns and breathing, which could help improve your care.
Paris, ParisAges 18 years+ - NCT06550687Recruiting
Studying how cancer patients like to learn about genetic results
This trial looks at the best ways to give cancer patients their genetic information before a special test called exome analysis. It aims to make sure you get the information in a way that feels right for you.
DijonAges 18 years+ - NCT06555900Recruiting
Predicting brain pressure spikes in injured patients using AI
This study is testing if an artificial intelligence program can predict dangerous increases in pressure inside the skull of people with brain injuries. If successful, it could help doctors treat these episodes sooner.
BrestAges 18–99 - NCT06974123Enrolling by invitationPhase 1/Phase 2
Testing a new oral drug for radiation proctitis
This trial tests an oral drug called Teslanbaicin for people who have pelvic cancer and developed radiation proctitis (inflammation of the rectum from radiation therapy). The goal is to see if it is safe and helps heal the inflammation.
Xinxiang, HenanAges 18 years+ - NCT07135102RecruitingPhase 1
Radioactive drug for advanced prostate cancer
This study tests an experimental radioactive drug ([225Ac]Ac-PSMA-XT) that targets prostate cancer cells. It is for men whose prostate cancer has spread and stopped responding to standard hormone therapy and chemotherapy.
Jinan, ShandongAges 18 years+ - NCT07644403Enrolling by invitationPhase 1/Phase 2
CAR-T Cell Therapy for Advanced Solid Tumors
This trial tests IMC001, a new type of immune cell therapy designed to fight advanced solid cancers that have stopped responding to standard treatments. The therapy uses your own immune cells engineered to recognize and attack cancer cells.
BeijingAges 18–75 - NCT07063979Recruiting
Using a nerve-stimulation band to reduce nausea after weight-loss surgery
This trial tests if adding a small nerve-stimulation device (Reliefband) to standard recovery care can help prevent nausea and vomiting in the first 24 hours after robotic sleeve gastrectomy. If you are having this surgery and match the criteria, you may be able to join.
Plainsboro, New JerseyAges 18–75 - NCT06950112Recruiting
Comparing two breathing methods for obese patients during weight-loss surgery
This trial tests a personalized way of setting the breathing machine during weight-loss surgery to reduce lung stress. It compares a tailored approach with standard care in people with obesity.
Tanta, El GharbiaAges 18–60 - NCT07017868Recruiting
Uric acid and other blood markers in lupus kidney disease
This study looks at whether certain substances in the blood, such as uric acid, homocysteine, and interleukin-17, are higher in people with lupus-related kidney disease compared to healthy individuals. It aims to find new ways to monitor or understand the condition better.
SohagAges 18 years+ - NCT07229950RecruitingPhase 2
Experimental tablet for moderate to severe Ulcerative Colitis
This trial tests an experimental tablet, HRS-7085, for people with moderate to severe Ulcerative Colitis who haven't gotten enough help from standard treatments. The goal is to see if the drug can reduce inflammation and improve symptoms.
Chengdu, SichuanAges 18–75 - NCT07001826Recruiting
Custom plates to fix uneven jaw in facial asymmetry
This trial tests whether custom-made surgical plates can more accurately correct a tilted upper jaw (maxillary cant) in people with facial asymmetry. It aims to improve surgical precision and outcomes.
CairoAges 18 years+ - NCT06762249Enrolling by invitation
Combined therapy for arm recovery after stroke
This trial tests combining two rehabilitation methods (CIMT and Brunnstrom therapy) to help people who have had a stroke improve arm and hand function on their affected side.
Multan, Punjab ProvinceAges 40–70 - NCT06970639RecruitingPhase 3
Study comparing new targeted drug plus chemo vs osimertinib for lung cancer with brain tumors
This trial tests a new targeted therapy called furmonertinib combined with chemotherapy against the current standard osimertinib for people with a specific type of non-small cell lung cancer (NSCLC) that has spread to the brain. It aims to find a better treatment option for patients whose cancer cells have a common EGFR mutation.
Guangdong, GuangzhouAges 18 years+ - NCT05842928Recruiting
Deprescribing risky medicines in older adults with many medications
This study tests a patient-centered plan to safely reduce certain medicines that may cause side effects in older people who take many drugs. It aims to improve safety and comfort by lowering unnecessary use while keeping you well.
BielefeldAges 65 years+ - NCT05345418RecruitingPhase 1/Phase 2
Cord blood stem cell treatment for low male hormones
This trial tests whether umbilical cord stem cells can improve hormone-related sexual function in men with low testosterone and related symptoms. It’s an early-phase study, so the goal is to see safety and whether symptoms and hormone measures improve.
HanoiAges 50–70 - NCT06923813Recruiting
Measuring nutrient absorption in ICU patients on tube feeding
This study checks how well patients who are still in the hospital after an ICU stay absorb the nutrients from their tube feeding. A special test called bomb calorimetry will measure the calories in stool to see if the body is getting the energy it needs.
BrusselsAges 18 years+ - NCT06736964Enrolling by invitation
Testing new fillings for gum-line cavities in high-risk adults
This study tests how well two newer, tooth-friendly filling materials work for cavities at the gum line in people who are prone to tooth decay. If you need a couple of these fillings, this trial could help restore your teeth and protect them from future cavities.
CairoAges 25–45
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,776 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.